Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-26 @ 1:57 AM
Study NCT ID:
NCT00601705
Status:
COMPLETED
Last Update Posted:
2019-04-30
First Post:
2008-01-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2012-03-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-23
First Submit QC Date:
None
Study First Post Date:
2008-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-21
Results First Submit QC Date:
None
Results First Post Date:
2019-04-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-18
Last Update Post Date:
2019-04-30
Last Update Post Date Type:
ACTUAL